Adrenal Ganglioneuroblastoma in Adults: A Case Report and Review of the Literature
Table 2
International Neuroblastoma Risk Group Consensus Pretreatment Classification Scheme.
INRG Stage
Age (months)
INPC group
Grade of differentiation
MYCN gene
11q aberration
Ploidy
Pretreatment risk group
L1/L2
GN maturing; GNB intermixed
Very low
L1 Localized tumor confined to one body compartment and with absence of image-defined risk factors
Any, except GN maturing or GNB intermixed
NA Amplified
Very low High
L2 Locoregional tumor with presence of one or more image-defined risk factor
<18
Any, except GN maturing or GNB intermixed
NA
No
Low
Yes
Intermediate
≥18
GNB nodular; NB
Differentiating
NA
No
Low
Yes
Intermediate
Poorly differentiated or undifferentiated
NA
Amplified
High
M Distant metastatic disease (except MS)
<18
NA
Hyperploid
Low
<12
NA
Diploid
Intermediate
12–18
NA
Diploid
Intermediate
<18
Amplified
High
≥18
High
MS Metastatic disease confined to skin, liver, and/or bone marrow in children <18 months
NA
no
Very low
yes
High
Amplified
High
INRG: International Neuroblastoma Risk Group; INCP: International Neuroblastoma Pathology Classification; GN = ganglioneuroma; GNB = ganglioneuroblastoma; NB = neuroblastoma; NA: not amplified; modified from Cohn et al. [11].